We've Raised $10 Million to Expand Access to Clinical Trials as a Care Option

We're excited to share that Trial Library has raised $10 million in Series A funding, co-led by Next Ventures and SemperVirens Venture Capital, with participation from Sanofi Ventures, Lux Capital, Civilization Ventures, Overwater Ventures, How Women Invest and others.

This investment accelerates our mission to make clinical research a core part of standard care - bridging access gaps for patients, empowering healthcare providers, and creating a more efficient and equitable research ecosystem.

Why This Matters

As our CEO and founder Dr. Hala Borno puts it: "As a physician-scientist, I witnessed first-hand the significant impact clinical trials have on improved healthcare outcomes. At Trial Library, we're building the connective tissue that links care delivery and clinical research. This Series A will enable us to advance our model where access to innovation is the standard - not the exception."

The reality is that 85% of cancer patients receive care in community settings, yet access to clinical trials has historically been concentrated in academic medical centers. We're changing that.

What We're Building

Our AI-enabled platform unlocks access to clinical trials in community-based clinical settings through provider activation, compliant patient identification, and longitudinal navigation throughout the trial lifecycle. We currently work across 320+ clinics and 1,500+ providers nationwide, and we're rapidly expanding our network alongside growing partnerships with payers including self-insured plans and health plans.

Lance Armstrong, Managing Partner at NEXT Ventures, noted: "Trial Library's approach aligns with the growing shift toward decentralized, community-based research. They're proving that AI and human navigation together can bring precision medicine to every corner of healthcare."

We're the first platform to unlock the payer market for clinical trial access, aligning incentives across patients, providers, payers, and life-science partners. Allison Baum Gates, General Partner at SemperVirens Venture Capital, shared: "We're excited to back a platform that aligns incentives and unites patients, providers, payers, and life-science partners around shared cost-savings and patient outcomes."

We've also partnered with leading global biopharmaceutical manufacturers to accelerate R&D and enrollment. Cris De Luca, Partner at Sanofi Ventures, said: "Trial Library is a uniquely end-to-end platform, building the infrastructure that will accelerate access to the next generation of precision medicine."

What's Next

This funding will help us expand our network, deepen our partnerships, and continue building the infrastructure that makes clinical trials accessible as a standard care option. We're grateful to our investors, partners, and the providers and patients who trust us with this important work.

If you're interested in learning more about how to work with Trial Library, reach out to us at info@triallibrary.com.

Read the full press release here.

‍